Robert A. Copeland
- Molecular Biology top 1%
- Oncology top 5%
- Pathology and Forensic Medicine top 2%
- Hematology top 2%
- Cancer Research top 5%
- Co-authors
- Victoria M. RichonMargaret Porter ScottRoy M. PollockSarah K. KnutsonKevin W. KuntzMikel P. MoyerHeike KeilhackRichard Chesworth
- Topics
- Epigenetics and DNA Methylation (39 papers)Cancer-related gene regulation (38 papers)RNA modifications and cancer (12 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Robert A. Copeland
66 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Molecular Biology 4.3k
- Oncology 508
- Pathology and Forensic Medicine 465
- Hematology 402
- Cancer Research 355
Countries citing papers authored by Robert A. Copeland
This map shows the geographic impact of Robert A. Copeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Copeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Copeland more than expected).
Fields of papers citing papers by Robert A. Copeland
This network shows the impact of papers produced by Robert A. Copeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Copeland. The network helps show where Robert A. Copeland may publish in the future.
Co-authorship network of co-authors of Robert A. Copeland
This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Copeland. A scholar is included among the top collaborators of Robert A. Copeland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Copeland. Robert A. Copeland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 52 | |
| 3 | 46 | |
| 4 | 127 | |
| 5 | 12 | |
| 6 | 31 | |
| 7 | 96 | |
| 8 | 55 | |
| 9 | 44 | |
| 10 | Potent inhibition of DOT1L as treatment of MLL-fusion leukemiabreakdown → | 546 |
| 11 | 116 | |
| 12 | 151 | |
| 13 | Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomasbreakdown → | 500 |
| 14 | 372 | |
| 15 | 7 | |
| 16 | 103 | |
| 17 | 3 | |
| 18 | 7 | |
| 19 | 11 | |
| 20 | 111 |
About Robert A. Copeland
Robert A. Copeland is a scholar working on Molecular Biology, Hematology and Cellular and Molecular Neuroscience, having authored 66 papers that have together received 5.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (39 papers), Cancer-related gene regulation (38 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Molecular Biology (4.3k citations), Hematology (402 citations) and Pathology and Forensic Medicine (465 citations). Robert A. Copeland has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Victoria M. Richon, Margaret Porter Scott, Roy M. Pollock, Sarah K. Knutson, Kevin W. Kuntz, Mikel P. Moyer, Heike Keilhack, Richard Chesworth, Michael E. Solomon and Tim J. Wigle. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.